Symbol
CTNM on Nasdaq
Investment type
Equity / Class A Common Stock, $0.001 par value per share
Latest Disclosed Shares Owned
950,786 shares
Security Ownership %
5%
Shares, Excluding Options vs Price
Value, Excluding Options

Jerome G. Pfund ownership in Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM)

14 Feb 2025 - Jerome G. Pfund has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 950,786 shares of Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM). This represents 5% ownership of the company. This is the first filing by SECTORAL ASSET MANAGEMENT INC disclosing ownership of Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.